These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 2901341)

  • 21. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas.
    Mojsov S; Weir GC; Habener JF
    J Clin Invest; 1987 Feb; 79(2):616-9. PubMed ID: 3543057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of PHI on hormonal secretion from perfused rat pancreas.
    Szecówka J; Tendler D; Efendić S
    Am J Physiol; 1983 Oct; 245(4):E313-7. PubMed ID: 6137956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucagon-like peptide-1 structure, function and potential use for NIDDM.
    Gefel D; Barg Y; Zimlichman R
    Isr J Med Sci; 1997 Oct; 33(10):690-5. PubMed ID: 9397146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory actions of a somatostatin analog SMS 201-995 on endocrine secretion from the isolated perfused stomach and pancreas of the rat.
    Verchere CB; Kwok YN; Brown JC
    Pharmacology; 1993; 46(1):50-60. PubMed ID: 8094569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multiple actions of GLP-1 on the process of glucose-stimulated insulin secretion.
    MacDonald PE; El-Kholy W; Riedel MJ; Salapatek AM; Light PE; Wheeler MB
    Diabetes; 2002 Dec; 51 Suppl 3():S434-42. PubMed ID: 12475787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon-like peptide-1 is a physiological incretin in rat.
    Wang Z; Wang RM; Owji AA; Smith DM; Ghatei MA; Bloom SR
    J Clin Invest; 1995 Jan; 95(1):417-21. PubMed ID: 7814643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
    Holst JJ
    Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GLP-1 in NIDDM.
    Holst JJ
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S156-60. PubMed ID: 8894501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GLP-1 and the gut.
    Thompson DG
    Gut; 2000 May; 46(5):591. PubMed ID: 10764696
    [No Abstract]   [Full Text] [Related]  

  • 30. The entero-insular axis in type 2 diabetes--incretins as therapeutic agents.
    Creutzfeldt W
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S288-303. PubMed ID: 11460578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of incretin hormones.
    Efendic S; Portwood N
    Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of spontaneous diabetes on hormone release in BB/Phi rats: comparison between the isolated perfused pancreas/stomach/duodenum/spleen and the isolated perfused pancreas.
    Boden G; Naji A; Barker CF; June V; Matschinsky FM
    Endocrinology; 1983 May; 112(5):1777-81. PubMed ID: 6131815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion.
    Fujita Y; Wideman RD; Asadi A; Yang GK; Baker R; Webber T; Zhang T; Wang R; Ao Z; Warnock GL; Kwok YN; Kieffer TJ
    Gastroenterology; 2010 May; 138(5):1966-75. PubMed ID: 20138041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
    Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
    Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach.
    Jia X; Brown JC; Kwok YN; Pederson RA; McIntosh CH
    Can J Physiol Pharmacol; 1994 Oct; 72(10):1215-9. PubMed ID: 7882187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?
    Whalley NM; Pritchard LE; Smith DM; White A
    J Endocrinol; 2011 Oct; 211(1):99-106. PubMed ID: 21795304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM.
    Thorens B; Waeber G
    Diabetes; 1993 Sep; 42(9):1219-25. PubMed ID: 8349031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum.
    Hansen L; Hartmann B; Bisgaard T; Mineo H; Jørgensen PN; Holst JJ
    Am J Physiol Endocrinol Metab; 2000 Jun; 278(6):E1010-8. PubMed ID: 10827002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets.
    Kieffer TJ; Heller RS; Unson CG; Weir GC; Habener JF
    Endocrinology; 1996 Nov; 137(11):5119-25. PubMed ID: 8895386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.